281
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Body Composition and Handgrip Strength with Interleukin-6 (IL-6) and Vitamin D Level in Cancer Patients

, , , &
Pages 1995-2001 | Received 30 Sep 2022, Accepted 28 Apr 2023, Published online: 23 May 2023

References

  • Camperi A, Pin F, Costamagna D, et al. Vitamin D and VDR in cancer cachexia and muscle regeneration. Oncotarget. 2017;8(13):21778–21793. doi:10.18632/oncotarget.15583
  • Bourdel-Marchasson I, Diallo A, Bellera C, et al. One-year mortality in older patients with cancer: development and external validation of an MNA-based prognostic score. PLoS One. 2016;11(2):1–16. doi:10.1371/journal.pone.0148523
  • Rounis K, Makrakis D, Tsigkas A-P, et al. Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study. Transl Lung Cancer Res. 2021;10(8):3538–3549.
  • Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
  • Kim S-H, Kwon HS, Hwang H-J. White blood cell counts, insulin resistance, and vitamin D levels and sarcopenia in Korean elderly men. Scand J Clin Lab Invest. 2017;77:228–233.
  • Garcia M, Seelaender M, Sotiropoulos A, Coletti D, Lancha AH. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy. Nutrition. 2019;60:66–69. PMID: 30529188. doi:10.1016/j.nut.2018.09.031
  • Van Veldhuizen PJ, Taylor SA, Williamson S and Drees BM. Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. Journal of Urology. 2000;163(1):187–190. doi:10.1016/S0022-5347(05)68001-9
  • Zeichner SB, Koru-Sengul T, Shah N, et al. Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer. Clinical Breast Cancer. 2015;15(1):e1–e11. doi:10.1016/j.clbc.2014.08.001
  • Miroliaee AE, Salamzadeh J, Shokouhi S, Sahraei Z. The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care. 2018;44:300–305.
  • Paval DR, Patton R, McDonald J, et al. A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle. 2022;13(2):824–838. doi:10.1002/jcsm.12912
  • Visser MPJ, Dofferhoff ASM, van den Ouweland JMW, et al. Effects of Vitamin D and K on Interleukin-6 in COVID-19 [Internet]. Front Nutr. 2022;8. doi:10.3389/fnut.2021.761191
  • Han J, Lu C, Meng Q, Halim A, Yean TJ, Wu G. Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients. Nutr Metab. 2019;16(1):80. doi:10.1186/s12986-019-0409-9
  • Hou Y-C, Wang C-J, Chao Y-J, et al. Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med. 2018;7(12):15.
  • Baltgalvis KA, Berger FG, Pena MMO, Davis JM, Muga SJ, Carson JA. Interleukin-6 and cachexia in Apc (Min/+) mice. Am J Physiol Integr Comp Physiol. 2008;294(2):R393–R401.
  • Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381–410.
  • Pettersen K, Andersen S, Degen S, et al. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Sci Rep. 2017;7(1):2046. doi:10.1038/s41598-017-02088-2
  • Ceglia L. Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care. 2009;12(6):628–633. doi:10.1097/MCO.0b013e328331c707
  • White JP. IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm. Transl Cancer Res. 2017;6(Suppl 2):S280–S285.
  • Han J, Meng Q, Shen L, Wu G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018;17(1):14. doi:10.1186/s12944-018-0657-0
  • Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321–335.
  • Nejatinamini S, Debenham BJ, Clugston RD, et al. Poor vitamin status is associated with skeletal muscle loss and mucositis in head and neck cancer patients. Nutrients. 2018;10:1236.
  • Verlaan S, Maier AB, Bauer JM, et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults – the PROVIDE study. Clin Nutr. 2018;37(2):551–557. doi:10.1016/j.clnu.2017.01.005
  • Gordon PL, Sakkas GK, Doyle JW, Shubert T, Johansen KL. Relationship between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr off J Counc Ren Nutr Natl Kidney Found. 2007;17(6):397–407.
  • Marcinkowska E. A run for a membrane vitamin D receptor. Biol Signals Recept. 2001;10(6):341–349.